In the ceremony, President Rouhani underscored the country's scientific growth in various fields, including mass production of medicines and vaccines.
The pentavalent vaccine is five individual vaccines conjugated in one intended to actively protect infant children from 5 potentially deadly diseases: Haemophilus Influenza type B, Whooping Cough (or Pertussis), Tetanus, Hepatitis B and Diphtheria.
Early in May, President Rouhani said Iran will gain self-sufficiency in meeting its needs to all the different types of vaccines and medicines in the near future, and said Iran can turn into a health and hygiene hub in the region.
"In hygiene and treatment areas, we will gain self-sufficiency and will be needless (of foreign countries' assistance) in many fields, including vaccine and medication, in the next two to four years," Rouhani said.
Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.
Earlier this year, Iranian Deputy Health Minister for Research and Technology Mostafa Qaneyee announced that Iran will start mass-production of 10 new home-made biomedicines in the next few years.
“These 10 drugs include medicines to treat cancer, infertility, rheumatoid arthritis, osteoporosis, MS, Crohn's disease, gout, hemophilia and diabetic ulcers and have applications in healing wounds and burns and blood production,” Qaneyee said.
“A number of the mentioned medicines have applications as multipurpose drugs for treating diseases like cancer, as well as (diseases caused during) chemotherapy stages and hepatitis C,” he added.
“The industrial and semi-industrial stages of producing the mentioned drugs will be gradually completed between the next 2 to 3 years,” Qanayee underlined.
